Molecular Partners Ag (MOLN) Payables (2020 - 2025)

Molecular Partners Ag (MOLN) has reported Payables for 6 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.

• Quarterly Payables rose 4.18% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 4.18% YoY) and the FY2025 annual result came in at $2.2 million, up 4.18% from the prior year.
• Payables slipped to $2.2 million in Q4 2025 per MOLN's latest filing, from $2.4 million in the prior quarter.
• Over the last five years, Payables for MOLN reached as high as $8.0 million in Q4 2021 and fell as low as $1.5 million in Q4 2023.
• A 5-year average of $3.4 million and a median of $2.4 million in 2025 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables plunged 72.24% — and 2024, when it soared 41.74%.
• Year by year, Payables stood at $8.0 million in 2021, then plunged by 72.24% to $2.2 million in 2022, then sank by 32.7% to $1.5 million in 2023, then jumped by 41.74% to $2.1 million in 2024, then rose by 4.18% to $2.2 million in 2025.
• According to Business Quant data, Payables over the past three periods registered $2.2 million, $2.4 million, and $2.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.